Rutishauser Jonas, Spiess Martin, Kopp Peter
Kantonsspital Baselland, Department of Medicine, CH-4101 Bruderholz, Switzerland; University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.
University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):249-62. doi: 10.1016/j.beem.2016.02.008. Epub 2016 Feb 18.
Neurohypophyseal diabetes insipidus is characterized by polyuria and polydipsia owing to partial or complete deficiency of the antidiuretic hormone, arginine vasopressin (AVP). Although in most patients non-hereditary causes underlie the disorder, genetic forms have long been recognized and studied both in vivo and in vitro. In most affected families, the disease is transmitted in an autosomal dominant manner, whereas autosomal recessive forms are much less frequent. Both phenotypes can be caused by mutations in the vasopressin-neurophysin II (AVP) gene. In transfected cells expressing dominant mutations, the mutated hormone precursor is retained in the endoplasmic reticulum, where it forms fibrillar aggregates. Autopsy studies in humans and a murine knock-in model suggest that the dominant phenotype results from toxicity to vasopressinergic neurons, but the mechanisms leading to cell death remain unclear. Recessive transmission results from AVP with reduced biologic activity or the deletion of the locus. Genetic neurohypophyseal diabetes insipidus occurring in the context of diabetes mellitus, optic atrophy, and deafness is termed DIDMOAD or Wolfram syndrome, a genetically and phenotypically heterogeneous autosomal recessive disorder caused by mutations in the wolframin (WFS 1) gene.
神经垂体性尿崩症的特征是由于抗利尿激素精氨酸加压素(AVP)部分或完全缺乏而导致多尿和烦渴。虽然在大多数患者中,非遗传性病因是该疾病的基础,但遗传形式早已得到体内和体外的认可与研究。在大多数受影响的家族中,该疾病以常染色体显性方式遗传,而常染色体隐性形式则较为少见。这两种表型都可能由加压素 - 神经垂体素II(AVP)基因突变引起。在表达显性突变的转染细胞中,突变的激素前体保留在内质网中,并在那里形成纤维状聚集体。对人类的尸检研究和小鼠基因敲入模型表明,显性表型是由对加压素能神经元的毒性导致的,但导致细胞死亡的机制仍不清楚。隐性遗传是由生物活性降低的AVP或该基因座的缺失引起的。在糖尿病、视神经萎缩和耳聋背景下发生的遗传性神经垂体性尿崩症被称为DIDMOAD或沃夫勒姆综合征,这是一种由沃尔弗拉姆蛋白(WFS 1)基因突变引起的遗传和表型异质性常染色体隐性疾病。